_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
The transaction is anticipated to close in the first quarter of 2022
The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition
The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
The consideration for the medicines in India is valued at Rs 180.48 crore
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
The acquisition complements and strengthens Merck’s cardiovascular pipeline
TCS to help Apoteket drive its digital transformation across sales channels and internal processes
Subscribe To Our Newsletter & Stay Updated
